UA95103C2 - Замещенные арилсульфонамиды в качестве противовирусных средств - Google Patents
Замещенные арилсульфонамиды в качестве противовирусных средствInfo
- Publication number
- UA95103C2 UA95103C2 UAA200811582A UAA200811582A UA95103C2 UA 95103 C2 UA95103 C2 UA 95103C2 UA A200811582 A UAA200811582 A UA A200811582A UA A200811582 A UAA200811582 A UA A200811582A UA 95103 C2 UA95103 C2 UA 95103C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antiviral agents
- substituted arylsulfonamides
- arylsulfonamides
- substituted
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
В заявке описаны замещенные арилсульфонамиды формулы (I) и способы их получения, а также их применение для приготовления лекарственных средств, предназначенных для лечения и/или профилактики заболеваний, особенно применения как противовирусных средств, преимущественно для борьбы с цитомегаловирусами.(I)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006009928A DE102006009928A1 (de) | 2006-03-03 | 2006-03-03 | Substituierte Arylsulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
UA95103C2 true UA95103C2 (ru) | 2011-07-11 |
Family
ID=38180640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200811582A UA95103C2 (ru) | 2006-03-03 | 2007-02-26 | Замещенные арилсульфонамиды в качестве противовирусных средств |
Country Status (26)
Country | Link |
---|---|
US (1) | US8318761B2 (ru) |
EP (1) | EP1991529B1 (ru) |
JP (1) | JP5255455B2 (ru) |
KR (1) | KR101447758B1 (ru) |
CN (1) | CN101389607B (ru) |
AR (1) | AR059710A1 (ru) |
AT (1) | ATE451356T1 (ru) |
AU (1) | AU2007222689B2 (ru) |
BR (1) | BRPI0707068A2 (ru) |
CA (1) | CA2642602C (ru) |
DE (2) | DE102006009928A1 (ru) |
DK (1) | DK1991529T3 (ru) |
ES (1) | ES2335316T3 (ru) |
HK (1) | HK1125371A1 (ru) |
IL (1) | IL193449A (ru) |
JO (1) | JO2581B1 (ru) |
MX (1) | MX2008011264A (ru) |
PE (1) | PE20080136A1 (ru) |
PL (1) | PL1991529T3 (ru) |
PT (1) | PT1991529E (ru) |
RU (1) | RU2423352C2 (ru) |
TW (1) | TWI388559B (ru) |
UA (1) | UA95103C2 (ru) |
UY (1) | UY30178A1 (ru) |
WO (1) | WO2007101573A1 (ru) |
ZA (1) | ZA200807189B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
EP2103316A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethandispersionen |
EP2103317A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
EP2103638A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Hydrophile Polyurethanlösungen |
EP2103318A1 (de) * | 2008-03-20 | 2009-09-23 | Bayer MaterialScience AG | Medizinische Geräte mit hydrophilen Beschichtungen |
DE102008025614A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
DE102008025613A1 (de) * | 2008-05-28 | 2009-12-03 | Bayer Materialscience Ag | Hydrophile Polyurethanbeschichtungen |
US8791200B2 (en) | 2008-09-04 | 2014-07-29 | Bayer Materialscience Ag | TCD based hydrophilic polyurethane dispersions |
DE102011101446A1 (de) | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
EP2853532B1 (en) * | 2013-09-28 | 2020-12-09 | Instytut Farmakologii Polskiej Akademii Nauk | 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III |
CN109879817B (zh) * | 2019-03-19 | 2020-10-02 | 扬州大学 | 甲基二磺隆的制备方法 |
RU2738848C1 (ru) * | 2019-10-24 | 2020-12-17 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
PL351374A1 (en) | 1999-04-19 | 2003-04-07 | Shionogi & Co | Sulfonamide derivatives having oxadiazole rings |
DE19920790A1 (de) * | 1999-05-06 | 2000-11-09 | Bayer Ag | Bis-Sulfonamide mit anti-HCMV-Wirkung |
DE19930075A1 (de) | 1999-06-30 | 2001-01-04 | Bayer Ag | Neue Amino- und Amidosulfonamide als antivirale Mittel |
DE50204780D1 (de) * | 2001-04-19 | 2005-12-08 | Bayer Healthcare Ag | Arylsulfonamide als antivirale mittel |
DE10138578A1 (de) * | 2001-08-06 | 2003-02-27 | Bayer Ag | Heterocyclylarylsulfonamide |
-
2006
- 2006-03-03 DE DE102006009928A patent/DE102006009928A1/de not_active Withdrawn
-
2007
- 2007-02-26 DE DE502007002264T patent/DE502007002264D1/de active Active
- 2007-02-26 PL PL07722932T patent/PL1991529T3/pl unknown
- 2007-02-26 AT AT07722932T patent/ATE451356T1/de active
- 2007-02-26 RU RU2008139195/04A patent/RU2423352C2/ru active
- 2007-02-26 PT PT07722932T patent/PT1991529E/pt unknown
- 2007-02-26 CN CN2007800066327A patent/CN101389607B/zh active Active
- 2007-02-26 ES ES07722932T patent/ES2335316T3/es active Active
- 2007-02-26 KR KR1020087024156A patent/KR101447758B1/ko active IP Right Grant
- 2007-02-26 EP EP07722932A patent/EP1991529B1/de active Active
- 2007-02-26 DK DK07722932.6T patent/DK1991529T3/da active
- 2007-02-26 CA CA2642602A patent/CA2642602C/en active Active
- 2007-02-26 MX MX2008011264A patent/MX2008011264A/es active IP Right Grant
- 2007-02-26 WO PCT/EP2007/001620 patent/WO2007101573A1/de active Application Filing
- 2007-02-26 JP JP2008557628A patent/JP5255455B2/ja not_active Expired - Fee Related
- 2007-02-26 UA UAA200811582A patent/UA95103C2/ru unknown
- 2007-02-26 BR BRPI0707068-3A patent/BRPI0707068A2/pt not_active Application Discontinuation
- 2007-02-26 AU AU2007222689A patent/AU2007222689B2/en not_active Ceased
- 2007-02-28 UY UY30178A patent/UY30178A1/es active IP Right Grant
- 2007-03-01 JO JO200762A patent/JO2581B1/en active
- 2007-03-02 AR ARP070100858A patent/AR059710A1/es not_active Application Discontinuation
- 2007-03-02 PE PE2007000224A patent/PE20080136A1/es active IP Right Grant
- 2007-03-02 TW TW096107166A patent/TWI388559B/zh active
-
2008
- 2008-08-14 IL IL193449A patent/IL193449A/en active IP Right Grant
- 2008-08-20 ZA ZA2008/07189A patent/ZA200807189B/en unknown
- 2008-09-03 US US12/203,793 patent/US8318761B2/en active Active
-
2009
- 2009-05-05 HK HK09104156.3A patent/HK1125371A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA95103C2 (ru) | Замещенные арилсульфонамиды в качестве противовирусных средств | |
NL300933I2 (nl) | Letermovir | |
HK1093729A1 (en) | Substituted quinolones | |
CA2897273C (en) | Benzylamine derivatives | |
TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
MX2009007104A (es) | Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina. | |
GB0625648D0 (en) | Compounds | |
MX2012004525A (es) | Compuestos. | |
MX2011008899A (es) | Nuevas orto-aminoamidas para el tratamiento del cancer. | |
TW200724532A (en) | Pyrimidinecarboxylic acid derivatives and their use | |
TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
WO2006089664A3 (de) | Heterocyclylamid-substituierte imidazole | |
MY150931A (en) | Substituted oxazolidinones and their use | |
MX2009001315A (es) | Compuestos de dimetilciclobutilo substituidos, su preparación y uso en medicamentos. | |
HK1112228A1 (en) | Substituted azachinzolines having an antiviral action | |
TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
IL187001A0 (en) | Preparation of (s)-4-fluromethyl-dihydro-furan -2-one | |
JO2999B1 (ar) | مركب ثلاثي حلقي و استخدامه الدوائي | |
UA95630C2 (ru) | Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства | |
GB0609897D0 (en) | Compounds | |
MY151590A (en) | Substituted quinolones iii | |
AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
ATE553088T1 (de) | Substituierte chinolone ii |